STAT3 and type 2 diabetes mellitus: Moreover, IL-6 activated stat3, increased stat3 phosphorylation, and inhibited the transcription and expression of zinc transporter SLC39A5, thereby increasing glucagon secretion and the risk of T2D (Chen et al., 2023).